PeploBio

PeploBio is a UK based ISO 15189 accredited Clinical Research Organization (CRO) which is committed to providing cutting-edge solutions to the biopharmaceutical and healthcare industry. The company offers access to the latest Molecular, Mass Spectrometry, Flow Cytometry, Sequencing, and ELISA-based technologies, enabling broad biomarker detection. As a science-led organization, PeploBio partners with clients to combat challenging testing needs by delivering bespoke services including assay development and assay validation. The highly experienced clinical and research-focused team of PeploBio, consisting of PhD and HCPC registered scientists, enables the company to be at the forefront of discovery, translational, and clinical research. The expertise of PeploBio includes assay development and validation services, regulatory affairs support, worldwide sample logistics and procurement, high sample testing capacity, and the use of state-of-the-art QMS recognized by leading regulatory bodies. The company also uses a Laboratory Information Management System (LIMS) to ensure streamlined, efficient, and secure operations and data management workflows. Founded in 2021, PeploBio is committed to enhancing precision medicine in the immune monitoring, cardiac, genomic, immunoassay, proteomic, and metabolomic space. Although the company's headquarters location and last investment details are not disclosed, the expertise and focus areas of PeploBio position it as a promising player in the Biopharma, Biotechnology, and Life Sciences industries.